"Watch and Wait" vs. Maintenance Treatment after Chemo with PARP Inhibitors
Presented by Jessica Moffett, Oncology Nurse Practitioner/Educator @ TESARO.
Date: April 25, 2019
Time: 6:30 PM to 7:30 PM
Join us via webinar, by computer or phone! Click this link PARP Inhibitors Education Webinar and watch along!
Meeting number: 621 287 474
OR, you may also join us by phone by dialing +1-510-338-9438
Access Code: 621 287 474
We suggest you join the meeting a few minutes early so you have enough time to download the WebEx software.
Only your gynecologic oncologist (or medical oncologist) will know if a PARP Inhibitor is right for you!
Currently, there are only three available PARP Inhibitors:
- Niraparib (aka Zejula) from Tesaro/GSK
- Olaparib (aka Lynparza) from Astra Zeneca/Merck
- Rucaparib (aka Rubraca) from Clovis Oncology